Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
about
Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer CachexiaEctopic expression of eIF2Bepsilon in rat skeletal muscle rescues the sepsis-induced reduction in guanine nucleotide exchange activity and protein synthesisRadiologically Determined Sarcopenia Predicts Morbidity and Mortality Following Abdominal Surgery: A Systematic Review and Meta-AnalysisDesign of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatiguAbsence of insulin signalling in skeletal muscle is associated with reduced muscle mass and function: evidence for decreased protein synthesis and not increased degradation.Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer.The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.Identification and functional clustering of genes regulating muscle protein degradation from amongst the known C. elegans muscle mutants.Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilizationReal-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexiaEnobosarm (GTx-024, S-22): a potential treatment for cachexia.Quantity of dietary protein intake, but not pattern of intake, affects net protein balance primarily through differences in protein synthesis in older adultsInducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia.Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.Cancer cell: using inflammation to invade the host.Association of interleukin-6 polymorphisms with susceptibility to hepatocellular carcinoma.Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivors.Study protocol: an evaluation of the effectiveness, experiences and costs of a patient-directed strategy compared with a multi-faceted strategy to implement physical cancer rehabilitation programmes for cancer survivors in a European healthcare systAmino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy.Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy.The origins of cachexia in acute and chronic inflammatory diseases.Cancer cachexia and anabolic interventions: a case report.Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life.Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone.The assessment and impact of sarcopenia in lung cancer: a systematic literature reviewBone Pain and Muscle Weakness in Cancer Patients.Centella asiatica modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC's)Exercise capacity, physical activity, and morbidity.Understanding tumor anabolism and patient catabolism in cancer-associated cachexiaC-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients.Skeletal Muscle Function During the Progression of Cancer Cachexia in the Male ApcMin/+ Mouse.The double-edged sword of endoplasmic reticulum stress in uremic sarcopenia through myogenesis perturbation.Effects of metformin on insulin resistance and metabolic disorders in tumor-bearing rats with advanced cachexia.Withania somnifera modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC's).Examining the Associations among Fibrocystic Breast Change, Total Lean Mass, and Percent Body Fat.
P2860
Q27334169-195892F5-E45E-46C5-B622-08DD5D7D2900Q28571670-09218D8E-53BF-4457-8330-525E6D2B2981Q29994656-8EA77E71-91A9-4FD4-ACFC-63647603AB7AQ33763960-929F00DE-24C5-4F2B-85CE-774AE3EA2722Q33819049-F9A46924-F29B-4439-A032-255E12ADCD97Q33890809-B6147C88-E3EC-47F7-9B0B-5928E93FA59FQ34029187-A9127C38-1751-45C4-B9A3-FB23AF876EF5Q34042815-89DDFA21-465C-43C9-8D25-2F4B0410D99FQ34203697-CA2BBD12-7702-4952-80B7-457CCF0CD7E6Q34312903-4921DE06-2BFA-497C-8B1D-B16A659216AAQ34401825-96C72F3F-D189-4E92-8EF0-EC68325B64D5Q34790537-DBAC1653-AB37-4CDD-BE6B-9459272EBBB4Q35254722-99036EBA-0739-4B44-A16C-0CF517606A8DQ35545370-68ED2494-A745-44F6-8401-160AE1C9A81EQ35759889-B44CFEA4-9803-41D5-827C-A666A2DC2C21Q35792086-4B331262-77E4-40DD-9382-E73B6C51FDFAQ35981535-6FA1E145-DCC8-4C57-8BDA-B54A712B9B1DQ36035063-2D3D14FD-092B-456B-A198-5F23D9364E87Q36359546-A1E7D5B5-5CD8-4D96-A57C-9CDC2BB47BF2Q36363858-4B7A731E-9D51-4905-A66D-7DDF10EC5C08Q36378758-09CA6E57-5219-461E-9FCF-200695D37CE4Q36421059-C2753C37-207D-4DF4-B957-1EB14893BAFBQ36755169-5ACF06B6-D008-4618-A255-FA9076D9D032Q37396676-A6323A7D-811F-4978-A793-1CBD3E65F3AEQ37516578-3D906715-4D86-4E41-BF98-D6C95E9E15C9Q38684768-19A64CD8-2264-4A5C-B00A-FF6E4EEE1AFBQ38695956-101B43B1-CE5E-4217-83FE-5BCFEB54CDFCQ39090266-9C84B86B-EF0D-4B91-B296-BEF302C6C835Q39339489-DB6871F6-3057-49EA-ABB5-467A8F7873ACQ46625663-60F3DCF1-A734-4D7A-BB8E-AE66097A1E9AQ47419257-EFF39CDF-E3BE-437F-8121-B4CB221F11FDQ47642967-A54424B6-174B-4A3D-8190-1AB10D04086AQ48520237-F117B341-8D71-49CA-8C50-5CCFE535501DQ52327749-E43B4AD9-9E4A-4D29-80B5-DCF6F6255FADQ55284010-2777BAD9-D425-4224-82C7-8D5D7DA82347
P2860
Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Molecular mechanisms involved ...... g: cachexia versus sarcopenia.
@ast
Molecular mechanisms involved ...... g: cachexia versus sarcopenia.
@en
type
label
Molecular mechanisms involved ...... g: cachexia versus sarcopenia.
@ast
Molecular mechanisms involved ...... g: cachexia versus sarcopenia.
@en
prefLabel
Molecular mechanisms involved ...... g: cachexia versus sarcopenia.
@ast
Molecular mechanisms involved ...... g: cachexia versus sarcopenia.
@en
P1476
Molecular mechanisms involved ...... g: cachexia versus sarcopenia.
@en
P2093
Francisco J López-Soriano
Josep M Argilés
P304
P356
10.1016/J.BIOCEL.2004.10.003
P577
2004-12-30T00:00:00Z